DE3128401A1 - 6-alkyl-1,2-dihydro-2-oxo-3-substituierte pyridinderivate und diese enthaltende arzneimittel - Google Patents

6-alkyl-1,2-dihydro-2-oxo-3-substituierte pyridinderivate und diese enthaltende arzneimittel

Info

Publication number
DE3128401A1
DE3128401A1 DE19813128401 DE3128401A DE3128401A1 DE 3128401 A1 DE3128401 A1 DE 3128401A1 DE 19813128401 DE19813128401 DE 19813128401 DE 3128401 A DE3128401 A DE 3128401A DE 3128401 A1 DE3128401 A1 DE 3128401A1
Authority
DE
Germany
Prior art keywords
oxo
dihydro
alkyl
neopentyl
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19813128401
Other languages
German (de)
English (en)
Inventor
Gilbert Arthur Michigan Youngdale
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of DE3128401A1 publication Critical patent/DE3128401A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/24—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19813128401 1980-08-29 1981-07-17 6-alkyl-1,2-dihydro-2-oxo-3-substituierte pyridinderivate und diese enthaltende arzneimittel Withdrawn DE3128401A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/182,554 US4288440A (en) 1980-08-29 1980-08-29 Pyridinones

Publications (1)

Publication Number Publication Date
DE3128401A1 true DE3128401A1 (de) 1982-04-22

Family

ID=22668973

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19813128401 Withdrawn DE3128401A1 (de) 1980-08-29 1981-07-17 6-alkyl-1,2-dihydro-2-oxo-3-substituierte pyridinderivate und diese enthaltende arzneimittel

Country Status (6)

Country Link
US (1) US4288440A (enExample)
JP (1) JPS5777675A (enExample)
DE (1) DE3128401A1 (enExample)
FR (1) FR2489330A1 (enExample)
GB (1) GB2083024B (enExample)
IT (1) IT1138504B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645766A (en) * 1981-10-19 1987-02-24 The Upjohn Company 1,2-dihydro-2-oxo-3-hydroxymethyl pyridines, compositions and use
US4451469A (en) * 1982-12-16 1984-05-29 Sterling Drug Inc. Selected 6-alkyl-and 4,6-dialkyl-2(1H)-pyridinones as cardiotonics

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3378564A (en) * 1964-12-15 1968-04-16 Pfizer & Co C Certain pyridyl tetrazole derivatives
US4028084A (en) * 1974-10-11 1977-06-07 Rohm And Haas Company Derivatives of 3-carboxy pyrid-2-ones
DE2635206A1 (de) 1976-08-05 1978-02-09 Cassella Farbwerke Mainkur Ag 3-formyl-4-methyl-2,6-dihydroxypyridin und ein verfahren zu seiner herstellung
DE2637477A1 (de) 1976-08-20 1978-02-23 Hoechst Ag Dihydro-oxo-nicotinsaeuren und verfahren zu ihrer herstellung
US4220648A (en) * 1979-01-22 1980-09-02 The Upjohn Company Antidiabetic 1,2-dihydro-2-oxo-6-neopentyl-nicotinic acids

Also Published As

Publication number Publication date
JPS5777675A (en) 1982-05-15
IT1138504B (it) 1986-09-17
FR2489330B1 (enExample) 1984-12-21
US4288440A (en) 1981-09-08
FR2489330A1 (fr) 1982-03-05
GB2083024B (en) 1984-05-23
IT8123641A0 (it) 1981-08-25
GB2083024A (en) 1982-03-17

Similar Documents

Publication Publication Date Title
EP0026317B1 (de) Optisch aktive 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE2516025A1 (de) Neue pyridinderivate, ihre herstellung und verwendung
CH660592A5 (de) Thiazolidinderivate mit ulcushemmender wirkung und verfahren zu ihrer herstellung.
DD237658A5 (de) Verfahren zur herstellung verbesserter entzuendungshemmender salze von piroxicam
DE69227080T2 (de) Thiazolidin-2,4-dione, salze hiervon sowie verfahren zur herstellung
DE2920250C2 (enExample)
WO1997028135A1 (de) 2,3-benzodiazepinderivate und deren verwendung als ampa-rezeptoren-hemmer
DE29924789U1 (de) Neue Kristallmodifikation N von Torasemid
DE3129275C2 (enExample)
EP0038343B1 (de) Substituierte oxocarbonsäuren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel
DE69005861T2 (de) Benzoxepin-Derivate.
DE2546196A1 (de) Pyrazolo eckige klammer auf 1,5-a eckige klammer zu pyridinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2952652A1 (de) 1,2-dihydro-2-oxonikotinsaeurederivate und diese enthaltende arzneimittel
DE3617976A1 (de) 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten
DE2059358A1 (de) Pyridon- und Thiopyridonderivate,die als entzuendungshemmende Mittel geeignet sind
DE3128401A1 (de) 6-alkyl-1,2-dihydro-2-oxo-3-substituierte pyridinderivate und diese enthaltende arzneimittel
DE2913295C2 (enExample)
EP0001108B1 (de) Neue 1,4-Dihydropyridazine, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln
DE102005028862A1 (de) Substituierte Heterocyclen, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10044905A1 (de) (2-Azabicyclo[2.2.1]hept-7-yl)methanol-Derivate als nikontinische Acetylcholinrezeptor Agonisten
DE2237832A1 (de) Verfahren zur herstellung von 4hydroxymethyl-1-keto-1,2-dihydrophthalazin
DE2550959B2 (de) Tetrazolyl-imidazole und Tetrazolyl--benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2162563C3 (de) l-(3',4'3'-Trimethoxybenzyl)-6-hydroxy-l,23,4-tetrahydroisochinoun
DE112004001572T5 (de) Verfahren
DE2919553A1 (de) Tetrahydroisochinolinderivat, verfahren zu seiner herstellung und es enthaltende arzneimittel

Legal Events

Date Code Title Description
8128 New person/name/address of the agent

Representative=s name: HENKEL, G., DR.PHIL. FEILER, L., DR.RER.NAT. HAENZ

8139 Disposal/non-payment of the annual fee